Literature DB >> 22373590

Cardiomyopathy of Friedreich's ataxia (FRDA).

R M Payne, R E Peverill.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22373590     DOI： 10.1007/s11845-012-0808-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  10 in total

Review 1.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

Review 2.  Friedreich's Ataxia: a review from a cardiology perspective.

Authors:  T Bourke; D Keane
Journal:  Ir J Med Sci       Date:  2011-08-07       Impact factor: 1.568

3.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

4.  Early changes in left ventricular long-axis function in Friedreich ataxia: relation with the FXN gene mutation and cardiac structural change.

Authors:  Philip M Mottram; Martin B Delatycki; Lesley Donelan; John S Gelman; Louise Corben; Roger E Peverill
Journal:  J Am Soc Echocardiogr       Date:  2011-05-12       Impact factor: 5.251

5.  Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience.

Authors:  R E Shaddy; L Y Tani; S S Gidding; E Pahl; G S Orsmond; E M Gilbert; V Lemes
Journal:  J Heart Lung Transplant       Date:  1999-03       Impact factor: 10.247

6.  Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia.

Authors:  Susan Michael; Simone V Petrocine; Jiang Qian; Jacques B Lamarche; Mitchell D Knutson; Michael D Garrick; Arnulf H Koeppen
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

7.  Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.

Authors:  Martin S Maron; Iacopo Olivotto; Andrey G Zenovich; Mark S Link; Natesa G Pandian; Jeffery T Kuvin; Stefano Nistri; Franco Cecchi; James E Udelson; Barry J Maron
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

8.  Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.

Authors:  H Puccio; D Simon; M Cossée; P Criqui-Filipe; F Tiziano; J Melki; C Hindelang; R Matyas; P Rustin; M Koenig
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330

9.  Marked variation in the cardiomyopathy associated with Friedreich's ataxia.

Authors:  D P Dutka; J E Donnelly; P Nihoyannopoulos; C M Oakley; D J Nunez
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

10.  Carvedilol for children and adolescents with heart failure: a randomized controlled trial.

Authors:  Robert E Shaddy; Mark M Boucek; Daphne T Hsu; Robert J Boucek; Charles E Canter; Lynn Mahony; Robert D Ross; Elfriede Pahl; Elizabeth D Blume; Debra A Dodd; David N Rosenthal; Jeri Burr; Bernie LaSalle; Richard Holubkov; Mary Ann Lukas; Lloyd Y Tani
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272
  10 in total
  4 in total

Review 1.  [Heart involvement in Friedreich's ataxia].

Authors:  F Weidemann; F Scholz; C Florescu; D Liu; K Hu; S Herrmann; G Ertl; S Störk
Journal:  Herz       Date:  2014-05-23       Impact factor: 1.443

Review 2.  Diagnosis and management of hypertrophic cardiomyopathy.

Authors:  Antonis Pantazis; Annina S Vischer; Maria Carrillo Perez-Tome; Silvia Castelletti
Journal:  Echo Res Pract       Date:  2015-03-11

3.  Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.

Authors:  QingQing Wang; Lili Guo; Cassandra J Strawser; Lauren A Hauser; Wei-Ting Hwang; Nathaniel W Snyder; David R Lynch; Clementina Mesaros; Ian A Blair
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

Review 4.  Heart disease in Friedreich's ataxia.

Authors:  Emily Hanson; Mark Sheldon; Brenda Pacheco; Mohammed Alkubeysi; Veena Raizada
Journal:  World J Cardiol       Date:  2019-01-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.